Paronychia in association with indinavir treatment.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 11118393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment-adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures-was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).
Medical subject headings
- HIV Infections
- HIV Protease Inhibitors
- HIV-1
- Indinavir
- Paronychia